Health authorities in England are launching a vaccination campaign targeting roughly one million young people with free meningitis B vaccine doses. The initiative follows an outbreak in Kent that occurred earlier this year, which resulted in 29 confirmed or suspected cases and two deaths. Nearly 90,000 doses have already been administered, with an additional 135,000 scheduled for the coming weeks.
The vaccine targets meningitis B, a dangerous bacterial strain responsible for the Kent outbreak. It is administered as two doses spaced at least 28 days apart, with both doses necessary for optimal protection. The vaccine does not contain live bacteria and cannot cause meningitis. Common side effects include localized swelling, redness, or tenderness at the injection site, along with mild fever, nausea, headache, or muscle aches that typically resolve within one to two days. Serious side effects are rare.
Eligibility includes 17 and 18-year-olds in sixth form and students under 25 beginning residential university or further education programs for the first time this autumn. Walk-in vaccine access is available at participating high street pharmacies for those born on or after 21 July 2001. Individuals can also book appointments through the NHS National Booking Service if registered with a general practitioner. International students and those from other UK nations studying in England are eligible, as are students relocating abroad for education.
Meningitis B infection poses serious health risks, potentially causing inflammation of the brain lining, blood poisoning, and life-threatening complications. Untreated bacterial meningitis can result in permanent disabilities including hearing loss, brain damage, and amputations, and may prove fatal. Infection spreads through close contact such as kissing, sharing personal items, or living in shared accommodation. University students have approximately seven times higher infection risk compared to non-university peers of similar age due to increased social mixing and communal living.
The MenB vaccine was incorporated into the routine UK childhood immunization schedule for infants born on or after 1 July 2015, but individuals over 11 have not previously received this protection through standard programs. Medical experts suggest the government should consider routine vaccination for all teenagers around age 15, though implementation decisions rest with individual UK nations. Meanwhile, health officials encourage all eligible individuals to obtain vaccination.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI